Phibro Animal Health (NASDAQ:PAHC) Reaches New 12-Month High at $18.64

Phibro Animal Health Co. (NASDAQ:PAHC - Get Free Report)'s share price hit a new 52-week high on Wednesday . The company traded as high as $18.64 and last traded at $18.64, with a volume of 7986 shares changing hands. The stock had previously closed at $18.37.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. Barclays upped their price objective on Phibro Animal Health from $10.00 to $13.00 and gave the stock an "underweight" rating in a report on Friday, May 10th. StockNews.com upgraded Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Tuesday, April 9th. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, Phibro Animal Health has an average rating of "Hold" and an average price target of $14.75.

Phibro Animal Health Price Performance

The company has a 50-day moving average price of $14.38 and a 200-day moving average price of $12.48. The firm has a market capitalization of $745.61 million, a P/E ratio of 58.06, a price-to-earnings-growth ratio of 6.04 and a beta of 0.63. The company has a debt-to-equity ratio of 1.69, a quick ratio of 1.67 and a current ratio of 3.16.

Phibro Animal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 26th. Stockholders of record on Wednesday, June 5th will be paid a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, June 5th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.61%. Phibro Animal Health's dividend payout ratio (DPR) is presently 150.00%.

Institutional Investors Weigh In On Phibro Animal Health

Hedge funds have recently bought and sold shares of the company. Brandes Investment Partners LP raised its stake in Phibro Animal Health by 38.5% during the 3rd quarter. Brandes Investment Partners LP now owns 1,873,300 shares of the company's stock worth $23,922,000 after buying an additional 520,697 shares during the period. Acadian Asset Management LLC grew its position in shares of Phibro Animal Health by 32.8% in the 1st quarter. Acadian Asset Management LLC now owns 675,207 shares of the company's stock valued at $8,726,000 after purchasing an additional 166,776 shares during the period. Wellington Management Group LLP increased its stake in Phibro Animal Health by 165.9% during the 4th quarter. Wellington Management Group LLP now owns 164,764 shares of the company's stock worth $1,908,000 after purchasing an additional 102,793 shares in the last quarter. GSA Capital Partners LLP raised its holdings in Phibro Animal Health by 227.0% during the 3rd quarter. GSA Capital Partners LLP now owns 81,647 shares of the company's stock worth $1,043,000 after buying an additional 56,676 shares during the period. Finally, BNP Paribas Financial Markets lifted its stake in Phibro Animal Health by 290.2% in the fourth quarter. BNP Paribas Financial Markets now owns 73,287 shares of the company's stock valued at $849,000 after buying an additional 54,506 shares in the last quarter. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.